Strategic growth
Specialty service lines
Volume, contribution margin, market share, and downstream revenue — one view across cardiology, orthopedics, oncology, women's health, and primary care.
Service lines
11
YoY case growth
+7.4%
Contribution margin
$184M
Active clinicians
612
Line performance — YTD
- Cardiology · Volume +12% · Margin +9%ok
- Orthopedics · Volume +6% · Margin flatinfo
- Oncology · Volume +4% · Margin +3%ok
- Women's health · Volume −2% · Margin −4%warn
- Primary care · Visits +14% · Panel +8%ok
Downstream revenue (per new patient)
- Cardiology consult → $4,820 over 12 mo
- Ortho consult → $6,140
- Bariatrics intake → $11,200
- Oncology second-opinion → $9,400
Investment scorecard
- Cardiology — expand structural heart (approved)
- Orthopedics — ASC partnership (pilot)
- Women's health — midwifery program (planning)
- Oncology — precision medicine lab (in build)